Potential Patchwork Of Local Drug Take-Back Programs Poses Problem For OTC Firms
This article was originally published in The Tan Sheet
CHPA backs litigation challenging drug take-back requirements to help stave off a patchwork of similar programs. Consumer education requires “a long-term commitment and won't be cheap,” but the OTC industry “can push back against more onerous mandates, says CHPA chief Scott Melville.
You may also be interested in...
Trade Group News: CHPA Social Media Award, AHPA Prop 65 Guidance For CBD, CRN Workshop Speakers, More
AHPA supports 2020 Smithsonian Folklife Festival ginseng program; NPA offers to help Amazon following its notification of potentially counterfeit Align probiotics sold; CRN Day of Science tackles "Healthy Aging"; UNPA partners with hemp industry group; Expo East Herb Walk goes to Green Farmacy; CHPA Educational Foundation KnowYourOTCs campaign named "Social Media Campaign of Year" by PR Daily; and AHPA publishes California Prop 65 compliance guidance for CBD marketers.
Officials from Mississippi, Missouri, Oregon and South Carolina and the National Narcotics Officers Associations Coalition testifying before a House subcommittee call for moving all PSE products to prescription status.
The Personal Care Products Council is engaging on state legislation for extended producer responsibility programs, which impose the cost of recycling plastic materials on manufacturers. Emerging bills to prohibit use of the ‘chasing arrows’ recycling symbol on consumer packaging also have the trade group’s attention.